These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 38767878)
21. Possible anticompetitive agreements between brand, generic companies to be studied. Landis NT Am J Health Syst Pharm; 2000 Dec; 57(23):2140, 2142. PubMed ID: 11127691 [No Abstract] [Full Text] [Related]
22. Teva v. Eisai: what's the real "controversy"? Wang GL Food Drug Law J; 2011; 66(4):631-54, iii. PubMed ID: 24505831 [TBL] [Abstract][Full Text] [Related]
23. Long-term Medicaid excess payments from alleged price manipulation of generic lorazepam. Bian B; Gorevski E; Kelton CM; Guo JJ; Martin Boone JE J Manag Care Pharm; 2012 Sep; 18(7):506-15. PubMed ID: 22971204 [TBL] [Abstract][Full Text] [Related]
24. How will recent trade agreements that extend market protections for brand-name prescription pharmaceuticals impact expenditures and generic access in Canada? Beall RF; Hardcastle L; Clement F; Hollis A Health Policy; 2019 Dec; 123(12):1251-1258. PubMed ID: 31601457 [TBL] [Abstract][Full Text] [Related]
25. The probable effects of Federal Trade Commission actions on dentistry and dental education. Conrad DA; Milgrom P J Dent Educ; 1982 Mar; 46(3):135-42. PubMed ID: 6948872 [TBL] [Abstract][Full Text] [Related]
26. IFTC v. Evanston: antitrust enforcement of hospital mergers receives a shot in the arm. Pak C; Cauley K J Health Life Sci Law; 2008 Jul; 1(4):95, 97-116. PubMed ID: 18717153 [TBL] [Abstract][Full Text] [Related]
27. The FTC v. Actavis roadmap: a guide to properly applying the rule of reason standard in reverse payment cases. Sharkey N J Leg Med; 2014; 35(3):445-66. PubMed ID: 25207633 [No Abstract] [Full Text] [Related]
28. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform. Kesselheim AS; Avorn J; Sarpatwari A JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619 [TBL] [Abstract][Full Text] [Related]
29. Federal trade commission regulation of food advertising to children: possibilities for a reinvigorated role. Mello MM J Health Polit Policy Law; 2010 Apr; 35(2):227-76. PubMed ID: 20388868 [TBL] [Abstract][Full Text] [Related]
30. An Administrative Meter Maid: Using Inter Partes Review and Post-Grant Review to Curb Exclusivity Parking via the "Failure to Market" Provision of the Hatch-Waxman Act. Apel BT Mich Law Rev; 2015; 114(1):107-36. PubMed ID: 26394458 [TBL] [Abstract][Full Text] [Related]
31. Competition and antitrust enforcement in the changing pharmaceutical marketplace. Whitener MD Food Drug Law J; 1995; 50(2):301-7. PubMed ID: 10342998 [No Abstract] [Full Text] [Related]
32. Your business in court and at federal agencies: 2010 - 2011. Reiss JB; Crowder D; Simons B; Pleskov I; Davis T; Nugent P Food Drug Law J; 2012; 67(2):243-92, iii. PubMed ID: 24620420 [TBL] [Abstract][Full Text] [Related]
33. Assertive or antiquated: ProMedica vows to appeal loss against FTC as questions loom over whether mergers lead to efficiencies or clout. Carlson J Mod Healthc; 2011 Dec; 41(50):6-7, 16, 1. PubMed ID: 22299225 [TBL] [Abstract][Full Text] [Related]
34. The FTC's role in health care. McCarey MC Bull Am Coll Surg; 1984 Apr; 69(4):18-21. PubMed ID: 10265677 [No Abstract] [Full Text] [Related]
35. Hoechst plans divestitures to gain FTC nod. Scott L Mod Healthc; 1995 Sep; 25(39):32. PubMed ID: 10151416 [No Abstract] [Full Text] [Related]
36. High court backs FTC's powers. Burda D Hospitals; 1986 Jul; 60(14):32. PubMed ID: 3721469 [No Abstract] [Full Text] [Related]
37. Generic Drugs in the United States: Policies to Address Pricing and Competition. Gupta R; Shah ND; Ross JS Clin Pharmacol Ther; 2019 Feb; 105(2):329-337. PubMed ID: 30471089 [TBL] [Abstract][Full Text] [Related]
38. The Drug Price Competition and Patent Term Restoration Act of 1984: fine-tuning the balance between the interests of pioneer and generic drug manufacturers. Soehnge H Food Drug Law J; 2003; 58(1):51-80. PubMed ID: 12739584 [No Abstract] [Full Text] [Related]
39. Updated trends in US brand-name and generic drug competition. Grabowski H; Long G; Mortimer R; Boyo A J Med Econ; 2016 Sep; 19(9):836-44. PubMed ID: 27064194 [TBL] [Abstract][Full Text] [Related]